A recent randomized controlled trial on children and adolescents with new-onset T1D showed that antiviral treatment (pleconaril and ribavirin) can preserve residual insulin production for at least one year after diagnosis, compared to placebo [63]. This evidence concerns the gene INS and type 1 diabetes mellitus.